Clinical Trial Update: GI-4000 With Adoptive Transfer in Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of GI-4000 with adoptive transfer for pancreatic cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• GI-4000

Snippet

Sponsor: University of Pennsylvania | Conditions: Pancreatic Cancer | Phase 1 | Status: WITHDRAWN